Effectiveness of systematic chromoendoscopy for diagnosis of early cancer and gastric premalignant lesions. Results of two consecutive screening campaigns in Colombia (2006-2007);Utilidad de la cromoendoscopia sistemática en el diagnóstico del cáncer temprano y lesiones gástricas premalignas. Resultado de dos campañas masivas consecutivas de tamización en Colombia (2006-2007)

Revista Colombiana de Gastroenterologia

Volumn 25, Issue 1, 2010, Pages 19-30

  Emura, Fabián ^a,b   Mejía, Juan ^a   Mejía, Marcela ^a   Osorio, Camilo ^b   Hernández, Carolina ^a   González, Iván ^a   Malaver, Omar ^a   Rodríguez, Constanza ^c   Oda, Ichiro ^d   Correa, Pelayo ^e  

^a EmuraCenter LatinoAmerica   (Colombia)

^b UNIVERSIDAD DE LA SABANA   (Colombia)

^c SaludCoop   (Colombia)

^d NATIONAL CANCER CENTER   (Japan)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

Early gastric cancer; H pilory; IT Knife2; Premalignant gastric lesion; Screening; Systematic chromoendocopy

Indexed keywords

EID: 77956975955     PISSN: 01209957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. WorldJ Gastroenterol 2006; 12(3): 354-362.
2. Pineros M, Ferlay J, Murillo R. Incidencia estimada y mortalidadpor cancer en Colombia. Instituto Nacional deCancerologia, 2005.
3. Miki K, Fujishiro M, Kodashima S, Yahagi N. Long-termresults of gastric cancer screening using the serum pepsinogentest method among an asymptomatic middle-agedJapanese population. Dig Endosc 2009; 21(2): 78-81.
4. Oda I, Saito D, Tada M, Iishi H, Tanabe S, Oyama T, et al. Amulticenter retrospective study of endoscopic resection forearly gastric cancer. Gastric Cancer 2006; 4: 262-70.
5. Castano R, Escobar J, Villamizar J, Oliveros R, Munoz A,Valvuena JV, et al. Carcinoma gastrico temprano: evaluacionde una serie de 109 pacientes. Rev Col de Cir 1998;13: 229-235.
6. Hosokawa O, Miyanaga T, Kaizaki Y, Hattori M, Dohden K,Ohta K, et al. Decreased death from gastric cancer by endoscopicscreening: association with a population-based cancerregistry. Scand J Gastroenterol 2008; 43(9): 1112-5.
7. Watabe H, Mitsushima T, Derakhshan MH, Yamaji Y,Okamoto M, Kawabe T, et al. Study of association between atrophic gastritis and body mass index: across-sectional study in 10,197 Japanese subjects. Dig Dis Sci 2009; 54(5):988-95.
8. Correa P. A human model of gastric carcinogenesis. CancerRes 1988; 48: 3554-60.
9. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E,Zarama G, et al. Gastric precancerous process in a highrisk population: cross-sectional studies. Cancer Res 1990;50(15): 4731-6.
10. Correa P. Is gastric cancer preventable? Gut 2004; 53(9):1217-9.
11. Fujii T, Iishi H, Tatsuta M, Hirasawa R, Uedo N, HifumiK, et al. Effectiveness of premedication with pronase for improving visibility during gastroendoscopy: a randomized controlled trial. Gastrointest Endosc 1998; 47(5): 382-7.
12. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English ed. Gastric Cancer 1998;1: 10-24
13. Nonaka S, Saito Y, Kozu T, Gotoda T, Oda I, Matsuda T, etal. Narrow Band Imaging (NBI) system is useful for detectionof superficial pharyngeal cancer in a high-risk population.Endoscopy 2005; 37(Suppl I): A267.
14. Muto M, Nakane M, Katada C, Sano Y, Ohtsu A, EsumiH, et al. Squamous cell carcinoma in situ at oropharyngealand hypopharyngeal mucosal sites. Cancer 2004; 101(6):1375-81.
15. Kida M, Kobayashi K, Saigenji K. Routine chromoendoscopyfor gastrointestinal diseases: indications revised.Endoscopy 2003; 35(7): 590-6.
16. Saito D, Boku N, Fujioka T, Fukuda Y, Matsushima Y, Sakaki, N, et al. Impact of H. pylori eradication on gastric atrophy:current status of the Japanese Intervention Trial (JITHPstudy). Proceedings of the 6th International Gastric CancerCongress. Yokohama, Japan. May 4-7. 2005.
17. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System.International Workshop on the Histopathology of Gastritis,Houston 1994. Am J Surg Pathol 1996; 20(10): 1161-81.
18. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, LechagoJ, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16: 1249-59.
19. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS,Dawsey SM, et al. The Vienna classification of gastrointestinalepithelial neoplasia. Gut 2000; 47(2): 251-5.
20. Emura F, Oda I, Ono H. Diseccion endoscopica de la submucosa(DES). Un procedimiento superior a la mucosectomiapara el tratamiento del cancer gastrico temprano. RevCol Gastroenterol 2007; 22: 209-216.
21. Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, SaitoD, et al. Endoscopic mucosal resection for treatment of earlygastric cancer. Gut 2001; 48: 225-9.
22. Uraoka T, Fujii T, Saito Y, Sumiyoshi T, Emura F, Bhandari P,et al. Effectiveness of glycerol as a submucosal injection for EMR. Gastrointestinal Endoscopy 2005; 61: 736-40.
23. Emura F, Ono H. Reseccion endoscopica en lesiones gastricas.En Roldan L, Hani A, Aponte D. Editores. Tecnicasen endoscopia digestiva. Asociacion Colombiana deEndoscopia Digestiva 2007. p. 251-8.
24. Everett SM, Axon ATR. Early gastric cancer: disease orpseudo-disease? Lancet 1998; 351: 1350-1352.
25. Tsukuma H, Oshima A, Narahara H, Morii T. Natural historyof early gastric cancer: a non-concurrent, long term,follow-up study. Gut 2000; 47: 618-621.
26. Hamashima C, Shibuya D, Yamazaki H, Inoue K, FukaoA, Saito H, et al. The Japanese guidelines for gastric cancerscreening. Jpn J Clin Oncol 2008; 38(4): 259-67.
27. Longo WE, Zucker KA, Zdon MJ, Modlin IM. Detectionof early gastric cancer in an aggressive endoscopic unit. AmSurg 1989; 55: 100-4.
28. Gomez M, Ricaurte O, Gutierrez O. Costo efectividad de laendoscopia alta como prueba diagnostica en una campanapara deteccion del cancer gastrico. Rev Col Gastroenterol 2009; 24: 3450.
29. Emura F. Estrategias actuales de diagnostico en cancergastrico estado 0. Gastroenterologia, hepatologia y endoscopiabasadas en la evidencia. Capitulo 7. 2008. p. 81-4.
30. Koga M, Arakawa K. On the application of enzymaticmucinolysis in x-ray diagnosis of the stomach. Nippon ActaRadiol 1964; 24: 1011-31.
31. Ida K, Okuda J, Nakazawa S, Yoshino J, Itoh M, Yokoyama, Y, et al. Clinical evaluation of premedication with KPD(Pronase) in gastroendoscopy-placebo-controlled doubleblind study in dye scattering endoscopy. Clin Rep 1991; 25:1793-804.
32. Kato S, Fujii T, Koba I, Sano Y, Fu KI, Parra-Blanco A, et al.Assessment of colorectal lesions using magnifying colonoscopyand mucosal dye spraying: can significant lesions bedistinguished? Endoscopy. 2001; 33(4): 306-10.
33. Emura F, Saito Y, Taniguchi M, Fujii T, Tagawa K, Yamakado, M. Further validation of magnifying chromocolonoscopyfor differentiating colorectal neoplastic polyps in ahealth screening center. J Gastroenterol Hepatol 2007; 22:1722-27.
34. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, ZaramaG, et al. Chemoprevention of gastric dysplasia: randomizedtrial of antioxidant supplements and anti-helicobacter pyloritherapy. J Natl Cancer Inst 2000; 92(23): 1881-1888.
35. Ley C, Mohar A, Guarner J, Herrera-Goepfert R, FigueroaL, S, Halperin D, et al. Helicobacter pylori eradication and gastricpreneoplastic conditions: a randomized, double- blind,placebo-controlled trial. Cancer Epidemiol Biomarkers Prev 2004; 1: 4-10.
36. Genta RM, Gurer IE, Graham DY, Krishnan B, Segura AM,Gutierrez O, et al. Adherence of Helicobacter pylori to areasof incomplete intestinal metaplasia in the gastric mucosa.Gastroenterology 1996; 111(5): 1206-11.
37. Emura F, Ono H. Comentarios al Editor. Rev ColGastroenterol 2007; 22: 249-250.
38. Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y,Shimoda T, et al. Incidence of lymph node metastasis fromearly gastric cancer: estimation with large number of cases attwo large centers. Gastric Cancer 2000; 3: 219-225.
39. Gotoda T, Sasako M, Ono H, Katai H, Sano T, Shimoda, T. Evaluation of the necessity for gastrectomy with lymphnode dissection for patients with submucosal invasive gastriccancer. Br J Surg 2001; 88: 444-9.
40. Ono H, Hasuike N, Inui T, Takizawa K, Ikehara H,Yamaguchi Y, et al. Usefulness of a novel electrosurgicalknife, the insulation-tipped diathermic knife-2, for endoscopicsubmucosal dissection of early gastric cancer. GastricCancer 2008; 11(1): 47-52.
41. Emura F, Ricaurte O, Mejia J, Osorio O, Sabbagh L, Oda I,et al. ESD for early gastric cancer in Colombia. A westernvalidation of the Japanese experience. Gastrointes Endosc 2009; 69(5): AB178.
42. Oda I, Gotoda T, Hamanaka H, Eguchi T, Saito Y, Matsuda, T, et al. Endoscopic submucosal resection for early gastriccancer: Technical feasibility, operation time and complicationsfrom a large consecutive series. Digest Endosc 2005;17: 54-57.
43. Minami S, Gotoda T, Ono H, Oda I, Hamanaka H. Completeendoscopic closure of gastric perforation induced by endoscopicresection of early gastric cancer using endoclips canprevent surgery (with video). Gastrointest Endosc 2006;63: 596-601.
44. Parra-Blanco A, Kaminaga N, Kojima T, Endo Y, Uragami; N, Okawa N, et al. Hemo clipping for postpolypectomy andpostbiopsy colonic bleeding. Gastrointest Endosc 2000; 51:37-41.
45. Tsuji I, Fukao A, Sugawara N, Shoji T, Kuwajima I, Hisamichi, S. Cost-Effectiveness Analysis of Screening for Gastric Cancer in Japan Tohoku J Exp Med 1991; 164: 279-284.
46. Rollan A, Ferreccio C, Gederlini A, Serrano C, Torres J,Harris P. Non-invasive diagnosis of gastric mucosal atrophyin an asymptomatic population with high prevalence of gastriccancer. World J Gastroenterol 2006; 12(44): 7172-8.
47. Silva S, Filipe MI, Pinho A. Variants of intestinal metaplasiain the evolution of chronic atrophic gastritis and gastriculcer. A follow up study. Gut 1990; 31: 1097-1104.
48. El-Zimaity HM, Ramchatesingh J, Saeed MA, Graham DY.Gastric intestinal metaplasia: subtypes and natural history. JClin Pathol 2001; 54: 679-683.
49. Rokkas T, Filipe MI, Sladen GE. Detection of an increasedincidence of early gastric cancer in patients with intestinalmetaplasia type III who are closely followed up. Gut 1991;32: 1110-1113.
50. Yoshida S, Saito D. Gastric premalignancy and cancerscreening in high-risk patients. Am J Gastroenterol 1996;91: 839-43.
51. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model.Gastroenterology 1997; 113: 1983-1991.
52. Graham DY. Helicobacter pylori infection is the primarycause of gastric cancer. J Gastroenterol 2000; 35 (Suppl 12):90-97.
53. El-Zimaity HMT, Gutierrez O, Kim JG, Akamatsu T, GurerIE, Simjee AE, et al. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol 2001; 96: 666-672.
54. Correa P, Cuello C, Fajardo LF, Haenszel W, Bolanos O, deRamirez B. Diet and gastric cancer: nutrition survey in ahigh risk area. J Natl Cancer Inst 1983; 70: 673-678.